Showing results (51-60 of 163) with videos related to

Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|April 1, 2026
Second-line liposomal irinotecan plus S-1 vs. liposomal irinotecan plus 5-fluorouracil in metastatic pancreatic cancer: The phase I/II randomized NAPAN trialAnne M Gehrels, Esther N Pijnappel, Eva H van Daalen, et al.
Endoscopy International Open|July 18, 2022
Epidemiological, clinical and endoscopic characteristics of colorectal neuroendocrine neoplasms: a population-based study in the NetherlandsAnkie Reumkens, Prapto Sastrowijoto, Heike I Grabsch, et al.
Scientific Reports|March 6, 2025
The gut microbiota during tamoxifen therapy in patients with breast cancerLars E Hillege, David J M Barnett, Janine Ziemons, et al.
Frontiers in Oncology|March 3, 2022
Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?Eva Versteijne, Ignace H J T de Hingh, Marjolein Y V Homs, et al.
British Journal of Cancer|January 11, 2020
Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trialAli Belkouz, Judith de Vos-Geelen, Ron A A Mathôt, et al.
Journal of Geriatric Oncology|February 5, 2017
Functional status decline in older patients with breast and colorectal cancer after cancer treatment: A prospective cohort studyDoris van Abbema, Arnée van Vuuren, Franchette van den Berkmortel, et al.
Clinical Nutrition ESPEN|November 22, 2024
Skeletal muscle is independently associated with grade 3-4 toxicity in advanced stage pancreatic ductal adenocarcinoma patients receiving chemotherapyMerel R Aberle, Mariëlle M E Coolsen, Gilles Wenmaekers, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2024
Altered whole blood thrombin generation and hyperresponsive platelets in patients with pancreatic cancerRuth Anne Laura Willems, Joke Konings, Dana Huskens, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 22, 2021
SOURCE-PANC: A Prediction Model for Patients With Metastatic Pancreatic Ductal Adenocarcinoma Based on Nationwide Population-Based DataHéctor G van den Boorn, Willemieke P M Dijksterhuis, Lydia G M van der Geest, et al.
International Journal of Cancer|July 25, 2019
Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence studyWillemieke P M Dijksterhuis, Rob H A Verhoeven, Marije Slingerland, et al.
Pageof 17